Form 4: Perrigo Director Jeffrey Kindler Reports Stock Transactions
SEC Form 4 Filing
Director Jeffrey Kindler reports acquisition and disposal of Perrigo Company plc ordinary shares and restricted stock units.
Summary
- On May 15, 2024, Jeffrey Kindler, a director of Perrigo Company plc, reported transactions involving the company's ordinary shares.
- Kindler acquired 8,764 ordinary shares through the vesting of restricted stock units at a price of $30.22 per share.
- He also disposed of 4,207 ordinary shares to cover tax obligations at a price of $30.22 per share.
- Following these transactions, Kindler directly owns 23,007 ordinary shares.
- Additionally, Kindler acquired 9,904 restricted stock units on May 14, 2024, which vest on May 14, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
- Comparable companies like Teva Pharmaceutical Industries Ltd. and Mylan N.V. (now Viatris) also require their directors and officers to file similar reports when trading company stock.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
- The filing ensures compliance with SEC regulations, maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2017-02-08 | Date of Power of Attorney execution. |
| 2024-05-14 | Date of restricted stock units acquisition. |
| 2024-05-15 | Date of ordinary shares acquisition and disposal. |
| 2024-05-16 | Date of signature for the Form 4 filing. |
| 2025-05-14 | Vesting date for 9,904 restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.